🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized pilot clinical trial studies the effects of electronic ciga...
Status
Completed
Location
Ohio State University Comprehensive Cancer Center
Start Date
2015-12-08
Trial ID
NCT02596685
Treatments Being Tested
Erlotinib may stop the growth of tumor cells by blocking the enzymes necess...
Status
Terminated
Location
University of Chicago Comprehensive Cancer Center
Start Date
2002-05
Trial ID
NCT00042835
RATIONALE: Studying samples of tissue from patients with cancer in the labo...
Status
Completed
Location
Multiple Locations
Start Date
2010-08-05
Trial ID
NCT01192750
Treatments Being Tested
This phase I trial studies the side effects and best dose of photodynamic t...
Status
Terminated
Location
Northwestern University
Start Date
2008-03
Trial ID
NCT00571558
Treatments Being Tested
The goal of this clinical trial is to test a new method for newborn screeni...
Status
Completed
Location
Rady Children's Hospital San Diego
Start Date
2023-03-13
Trial ID
NCT06276348
Treatments Being Tested
This phase II trial studies the best approach to combine chemotherapy and r...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2021-07-13
Trial ID
NCT04684368
This project will evaluate the impact of L-Citrulline, tetrahydrobiopterin ...
Status
Recruiting
Location
VA Salt Lake City Health Care System, Salt Lake City, UT
Start Date
2021-05-19
Trial ID
NCT06312748
Treatments Being Tested
This phase II trial is studying how well cediranib maleate works in treatin...
Status
Completed
Location
City of Hope
Start Date
2006-04
Trial ID
NCT00278343
Treatments Being Tested
This phase II trial tests how well the combination of WP1066 and radiation ...
Status
Recruiting
Location
Northwestern University
Start Date
2024-05-22
Trial ID
NCT05879250
This phase II trial is studying how well AKT inhibitor MK-2206 works in tre...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2010-10
Trial ID
NCT01253447
Treatments Being Tested